Article

AAO 2019 Retina Street Team: Allen C. Ho, MD

Author(s):

AAO 2019 Retina Street Team

Allen C. Ho, MD, discusses precision subretinal delivery for gene and cell therapy along with Ben Ko, engineering manager, Kaleidoscope Innovation, at the 2019 meeting of the American Academy of Ophthalmology in San Francisco, CA.

Newsletter

Don’t miss out—get Ophthalmology Times updates on the latest clinical advancements and expert interviews, straight to your inbox.

Subscribe Now!
Related Videos
(Image credit: Ophthalmology Times) Neda Shamie_Controversies in Modern Eye Care 2025
Related Content
50 years of visionary innovation: Leading ophthalmologists reflect on the field’s greatest breakthroughs
April 18th 2025

50 years of visionary innovation: Leading ophthalmologists reflect on the field’s greatest breakthroughs

EnVision Summit 2025: Advancing Ophthalmology and Optometry Together
November 19th 2024

Connect, learn, and innovate in a family-friendly atmosphere: What to expect at EnVision Summit 2025

Piecing it together: Does semaglutide fit the NAION puzzle?
April 15th 2025

Piecing it together: Does semaglutide fit the NAION puzzle?

EyePod podcast: Innovation Series: Expanding access to eye care, advice for aspiring innovators from DMEI ophthalmology residents (part 3)
November 1st 2024

Innovation Series: Expanding access to eye care, advice for aspiring innovators from DMEI ophthalmology residents (part 3)

Vantage Biosciences doses first patient in phase 2 study of VX-01, oral therapy for nonproliferative diabetic retinopathy
April 11th 2025

Vantage Biosciences doses first patient in phase 2 study of VX-01, oral therapy for nonproliferative diabetic retinopathy

Pykus Therapeutics completes enrollment in trial evaluating PYK-2101
April 11th 2025

Pykus Therapeutics completes enrollment in trial evaluating PYK-2101

© 2025 MJH Life Sciences

All rights reserved.